Introduction Peptide therapeutics represent a rapidly expanding class of biopharmaceuticals for the treatment of metabolic disease, cancer, and other chronic conditions
We recognized early on that while weight loss is the goal, muscle loss is a common and unwanted side effect of potent GLP-1 medications
Obesity rates increased after start of COVID-19 pandemic, new study shows The move comes as demand for weight-loss and diabetes drugs has surged globally, driven by their effectiveness in managing obesity and diabetes
Any product stating it delivers results equivalent to injectable tirzepatide has no data to back that up
Many clinics offer combinations with Vitamin C, B12, or other infusions for enhanced benefits
Rapid weight loss is the most common trigger of telogen effluvium (temporary hair shedding)